United States Biogenic Stimulant Market Report 2017

Name: United States Biogenic Stimulant Market Report 2017
Brand: QYResearch
SKU: U1778AEEECFEN
Price: 3800 USD
Availability: InStock

August 2017 | 107 pages | ID: U1778AEEECFEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Biogenic Stimulant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Biogenic Stimulant in these regions, from 2012 to 2022 (forecast).

United States Biogenic Stimulant market competition by top manufacturers/players, with Biogenic Stimulant sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

BASF SE
Dow AgroSciences
Dupont
Novozymes A/S
Isagro SAP
Sapec Group
Platform Specialty Products Corporation
Biolchim S.P.A
Valagro SAP
Koppert B.V
Biostadt India Limited
Italpollina SAP
Huma Gro

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

By Active Ingredients

Humic Substances
Seaweed Extracts
Microbial Amendments
Trace Minerals
Vitamins & Amino Acids
Others

By Type

Natural Biogenic Stimulant
Biosynthetic Biogenic Stimulant

By Crop Type

Cereals
Oilseeds
Fruits & Vegetables
Turfs & Ornaments
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biogenic Stimulant for each application, including

Foilar
Soil
Seed

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Biogenic Stimulant Market Report 2017

1 BIOGENIC STIMULANT OVERVIEW

1.1 Product Overview and Scope of Biogenic Stimulant
1.2 Classification of Biogenic Stimulant by Product Category
  1.2.1 United States Biogenic Stimulant Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Biogenic Stimulant Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Humic Substances
  1.2.4 Seaweed Extracts
  1.2.5 Microbial Amendments
  1.2.6 Trace Minerals
  1.2.7 Vitamins & Amino Acids
  1.2.8 Others
1.3 United States Biogenic Stimulant Market by Application/End Users
  1.3.1 United States Biogenic Stimulant Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Foilar
  1.3.3 Soil
  1.3.4 Seed
1.4 United States Biogenic Stimulant Market by Region
  1.4.1 United States Biogenic Stimulant Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Biogenic Stimulant Status and Prospect (2012-2022)
  1.4.3 Southwest Biogenic Stimulant Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Biogenic Stimulant Status and Prospect (2012-2022)
  1.4.5 New England Biogenic Stimulant Status and Prospect (2012-2022)
  1.4.6 The South Biogenic Stimulant Status and Prospect (2012-2022)
  1.4.7 The Midwest Biogenic Stimulant Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Biogenic Stimulant (2012-2022)
  1.5.1 United States Biogenic Stimulant Sales and Growth Rate (2012-2022)
  1.5.2 United States Biogenic Stimulant Revenue and Growth Rate (2012-2022)

2 UNITED STATES BIOGENIC STIMULANT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Biogenic Stimulant Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Biogenic Stimulant Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Biogenic Stimulant Average Price by Players/Suppliers (2012-2017)
2.4 United States Biogenic Stimulant Market Competitive Situation and Trends
  2.4.1 United States Biogenic Stimulant Market Concentration Rate
  2.4.2 United States Biogenic Stimulant Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Biogenic Stimulant Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES BIOGENIC STIMULANT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Biogenic Stimulant Sales and Market Share by Region (2012-2017)
3.2 United States Biogenic Stimulant Revenue and Market Share by Region (2012-2017)
3.3 United States Biogenic Stimulant Price by Region (2012-2017)

4 UNITED STATES BIOGENIC STIMULANT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Biogenic Stimulant Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Biogenic Stimulant Revenue and Market Share by Type (2012-2017)
4.3 United States Biogenic Stimulant Price by Type (2012-2017)
4.4 United States Biogenic Stimulant Sales Growth Rate by Type (2012-2017)

5 UNITED STATES BIOGENIC STIMULANT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Biogenic Stimulant Sales and Market Share by Application (2012-2017)
5.2 United States Biogenic Stimulant Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES BIOGENIC STIMULANT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 BASF SE
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biogenic Stimulant Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 BASF SE Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Dow AgroSciences
  6.2.2 Biogenic Stimulant Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Dow AgroSciences Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Dupont
  6.3.2 Biogenic Stimulant Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dupont Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novozymes A/S
  6.4.2 Biogenic Stimulant Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novozymes A/S Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Isagro SAP
  6.5.2 Biogenic Stimulant Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Isagro SAP Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sapec Group
  6.6.2 Biogenic Stimulant Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sapec Group Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Platform Specialty Products Corporation
  6.7.2 Biogenic Stimulant Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Platform Specialty Products Corporation Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Biolchim S.P.A
  6.8.2 Biogenic Stimulant Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Biolchim S.P.A Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Valagro SAP
  6.9.2 Biogenic Stimulant Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Valagro SAP Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Koppert B.V
  6.10.2 Biogenic Stimulant Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Koppert B.V Biogenic Stimulant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Biostadt India Limited
6.12 Italpollina SAP
6.13 Huma Gro

7 BIOGENIC STIMULANT MANUFACTURING COST ANALYSIS

7.1 Biogenic Stimulant Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biogenic Stimulant

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biogenic Stimulant Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biogenic Stimulant Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BIOGENIC STIMULANT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Biogenic Stimulant Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Biogenic Stimulant Sales Volume Forecast by Type (2017-2022)
11.3 United States Biogenic Stimulant Sales Volume Forecast by Application (2017-2022)
11.4 United States Biogenic Stimulant Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Biogenic Stimulant
Figure United States Biogenic Stimulant Market Size (K MT) by Type (2012-2022)
Figure United States Biogenic Stimulant Sales Volume Market Share by Type (Product Category) in 2016
Figure Humic Substances Product Picture
Figure Seaweed Extracts Product Picture
Figure Microbial Amendments Product Picture
Figure Trace Minerals Product Picture
Figure Vitamins & Amino Acids Product Picture
Figure Others Product Picture
Figure United States Biogenic Stimulant Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Biogenic Stimulant by Application in 2016
Figure Foilar Examples
Table Key Downstream Customer in Foilar
Figure Soil Examples
Table Key Downstream Customer in Soil
Figure Seed Examples
Table Key Downstream Customer in Seed
Figure United States Biogenic Stimulant Market Size (Million USD) by Region (2012-2022)
Figure The West Biogenic Stimulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Biogenic Stimulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Biogenic Stimulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Biogenic Stimulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Biogenic Stimulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Biogenic Stimulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Biogenic Stimulant Sales (K MT) and Growth Rate (2012-2022)
Figure United States Biogenic Stimulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Biogenic Stimulant Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Biogenic Stimulant Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Biogenic Stimulant Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Biogenic Stimulant Sales Share by Players/Suppliers
Figure 2017 United States Biogenic Stimulant Sales Share by Players/Suppliers
Figure United States Biogenic Stimulant Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Biogenic Stimulant Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Biogenic Stimulant Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Biogenic Stimulant Revenue Share by Players/Suppliers
Figure 2017 United States Biogenic Stimulant Revenue Share by Players/Suppliers
Table United States Market Biogenic Stimulant Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Biogenic Stimulant Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Biogenic Stimulant Market Share of Top 3 Players/Suppliers
Figure United States Biogenic Stimulant Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Biogenic Stimulant Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Biogenic Stimulant Product Category
Table United States Biogenic Stimulant Sales (K MT) by Region (2012-2017)
Table United States Biogenic Stimulant Sales Share by Region (2012-2017)
Figure United States Biogenic Stimulant Sales Share by Region (2012-2017)
Figure United States Biogenic Stimulant Sales Market Share by Region in 2016
Table United States Biogenic Stimulant Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Biogenic Stimulant Revenue Share by Region (2012-2017)
Figure United States Biogenic Stimulant Revenue Market Share by Region (2012-2017)
Figure United States Biogenic Stimulant Revenue Market Share by Region in 2016
Table United States Biogenic Stimulant Price (USD/MT) by Region (2012-2017)
Table United States Biogenic Stimulant Sales (K MT) by Type (2012-2017)
Table United States Biogenic Stimulant Sales Share by Type (2012-2017)
Figure United States Biogenic Stimulant Sales Share by Type (2012-2017)
Figure United States Biogenic Stimulant Sales Market Share by Type in 2016
Table United States Biogenic Stimulant Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Biogenic Stimulant Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biogenic Stimulant by Type (2012-2017)
Figure Revenue Market Share of Biogenic Stimulant by Type in 2016
Table United States Biogenic Stimulant Price (USD/MT) by Types (2012-2017)
Figure United States Biogenic Stimulant Sales Growth Rate by Type (2012-2017)
Table United States Biogenic Stimulant Sales (K MT) by Application (2012-2017)
Table United States Biogenic Stimulant Sales Market Share by Application (2012-2017)
Figure United States Biogenic Stimulant Sales Market Share by Application (2012-2017)
Figure United States Biogenic Stimulant Sales Market Share by Application in 2016
Table United States Biogenic Stimulant Sales Growth Rate by Application (2012-2017)
Figure United States Biogenic Stimulant Sales Growth Rate by Application (2012-2017)
Table BASF SE Basic Information List
Table BASF SE Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure BASF SE Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure BASF SE Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure BASF SE Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Dow AgroSciences Basic Information List
Table Dow AgroSciences Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dow AgroSciences Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure Dow AgroSciences Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure Dow AgroSciences Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Dupont Basic Information List
Table Dupont Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dupont Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure Dupont Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure Dupont Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Novozymes A/S Basic Information List
Table Novozymes A/S Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novozymes A/S Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure Novozymes A/S Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure Novozymes A/S Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Isagro SAP Basic Information List
Table Isagro SAP Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Isagro SAP Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure Isagro SAP Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure Isagro SAP Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Sapec Group Basic Information List
Table Sapec Group Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sapec Group Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure Sapec Group Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure Sapec Group Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Platform Specialty Products Corporation Basic Information List
Table Platform Specialty Products Corporation Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Platform Specialty Products Corporation Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure Platform Specialty Products Corporation Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure Platform Specialty Products Corporation Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Biolchim S.P.A Basic Information List
Table Biolchim S.P.A Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biolchim S.P.A Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure Biolchim S.P.A Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure Biolchim S.P.A Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Valagro SAP Basic Information List
Table Valagro SAP Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Valagro SAP Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure Valagro SAP Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure Valagro SAP Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Koppert B.V Basic Information List
Table Koppert B.V Biogenic Stimulant Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Koppert B.V Biogenic Stimulant Sales Growth Rate (2012-2017)
Figure Koppert B.V Biogenic Stimulant Sales Market Share in United States (2012-2017)
Figure Koppert B.V Biogenic Stimulant Revenue Market Share in United States (2012-2017)
Table Biostadt India Limited Basic Information List
Table Italpollina SAP Basic Information List
Table Huma Gro Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biogenic Stimulant
Figure Manufacturing Process Analysis of Biogenic Stimulant
Figure Biogenic Stimulant Industrial Chain Analysis
Table Raw Materials Sources of Biogenic Stimulant Major Players/Suppliers in 2016
Table Major Buyers of Biogenic Stimulant
Table Distributors/Traders List
Figure United States Biogenic Stimulant Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Biogenic Stimulant Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Biogenic Stimulant Price (USD/MT) Trend Forecast (2017-2022)
Table United States Biogenic Stimulant Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Biogenic Stimulant Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Biogenic Stimulant Sales Volume (K MT) Forecast by Type in 2022
Table United States Biogenic Stimulant Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Biogenic Stimulant Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Biogenic Stimulant Sales Volume (K MT) Forecast by Application in 2022
Table United States Biogenic Stimulant Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Biogenic Stimulant Sales Volume Share Forecast by Region (2017-2022)
Figure United States Biogenic Stimulant Sales Volume Share Forecast by Region (2017-2022)
Figure United States Biogenic Stimulant Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Biogenic Stimulant Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports